Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiviral and anticancer ribozymes

E Poeschla1, F Wong-Staal

  • 1Department of Medicine, University of California, La Jolla 92093-0665.

Current Opinion in Oncology
|November 1, 1994
PubMed
Summary

Ribozymes, RNA enzymes with RNase properties, show promise for gene therapy against HIV and cancer by targeting specific genetic sequences. Research is refining their use for enhanced cellular activity and clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal inheritance, cytology and macromolecular composition of defective chloroplasts in a variegated mutant of Nicotiana tabacum.

Planta·2014
Same author

Identification of a mutation in chloroplast DNA correlated with formation of defective chloroplasts in a variegated mutant of Nicotiana tabacum.

Planta·2014
Same author

Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.

Cell death and differentiation·2008
Same author

Development of new RNAi therapeutics.

Histology and histopathology·2006
Same author

NR4A1, 2, 3--an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis.

Histology and histopathology·2006
Same author

Generation of dendritic cells from lentiviral vector-transduced CD34+ cells from HIV+ donors.

Journal of medical virology·2003

Area of Science:

  • Molecular biology
  • Gene therapy
  • Biochemistry

Background:

  • Ribozymes possess site-specific RNase activity, making them candidates for gene therapy.
  • Applications are being explored for HIV infection and various cancers.

Purpose of the Study:

  • To investigate the application of ribozymes in gene therapy for HIV and cancer.
  • To map substrate recognition and cleavage requirements for ribozymes.
  • To explore methods for enhancing intracellular cleavage and resolving in vitro/cellular activity discrepancies.

Main Methods:

  • Site-specific RNase activity mapping.
  • In vitro and cellular assays for cleavage efficiency.
  • Targeting oncogene transcripts (bcr/abl, ras) and HIV-1 RNA.

Main Results:

  • Hammerhead and hairpin ribozymes demonstrate antiviral efficacy against HIV-1 in tissue culture.
  • Ribozymes successfully targeted oncogene transcripts in preliminary studies.
  • Ongoing research focuses on optimizing intracellular activity and understanding cleavage mechanisms.

Conclusions:

  • Ribozymes are a promising tool for gene therapy targeting viral infections and cancer.
  • Further research is needed to optimize ribozyme delivery and efficacy in clinical settings.
  • A phase I clinical trial for T-cell gene therapy is planned, indicating therapeutic potential.

Related Experiment Videos